CD47-blocking antibody confers metabolic benefits against obesity

CD47-blocking antibody is a well-known potential antibody drug for tumor immunotherapy. However, it is unclear whether CD47-blocking antibody can protect against metabolic disorders. We report that high-fat diet (HFD)-induced obesity increases CD47 expression, while exercise downregulates it in skeletal muscle. Administration of CD47-blocking antibody in mice prevents HFD-induced weight gain and glucose intolerance, enhances exercise capacity, and improves body composition and skeletal muscle mitochondrial function. Mechanistically, the protective effects conferred by CD47-blocking antibody are mediated through activation of AMP-activated protein kinase (AMPK) in skeletal muscle. Consistently, muscle-specific CD47-knockout mice show similar metabolic improvements, indicating a direct muscle-specific role of CD47 in regulating AMPK activation in vivo. Furthermore, the CD47-blocking antibody reduces the phosphorylation of heat shock protein 90α (HSP90α) to activate AMPK in skeletal muscle. In conclusion, CD47-blocking antibody confers metabolic benefits by activating the AMPK pathway in skeletal muscle.

Authors

Institutions

Publication Details

Journal
Cell Reports Medicine
Published
2025-04-22
DOI
https://doi.org/10.1016/j.xcrm.2025.102089
Citations
3
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
2.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD47-blocking antibody confers metabolic benefits against obesity

Kaijiang Yang, Yu Dong, Duran Qin, Zhen‐Ning Zhang et al.
3 citations
Cell Reports Medicine
Phagocytosis and Immune Regulation
2.39
article

CD47-blocking antibody confers metabolic benefits against obesity

Kaijiang Yang, Yu Dong, Duran Qin, Zhen‐Ning Zhang, Gaowei Wang, Yunhui Kong, Weida Li, Jingzhi Zhang, Qiaolin Deng, Feifei Huang, Mengting Gong, Qing He, Zian Chen, Zhejin Sheng, Y. J. Su, Shaorong Gao, Xiaobo Li, Hong Wang, Pei Yu, Minglu Xu, Jingyu Sun, Ping Hu, Xiangyi Chen, Zhaoyue Wang, R. Le
article en
3 citations

Abstract

CD47-blocking antibody is a well-known potential antibody drug for tumor immunotherapy. However, it is unclear whether CD47-blocking antibody can protect against metabolic disorders. We report that high-fat diet (HFD)-induced obesity increases CD47 expression, while exercise downregulates it in skeletal muscle. Administration of CD47-blocking antibody in mice prevents HFD-induced weight gain and glucose intolerance, enhances exercise capacity, and improves body composition and skeletal muscle mitochondrial function. Mechanistically, the protective effects conferred by CD47-blocking antibody are mediated through activation of AMP-activated protein kinase (AMPK) in skeletal muscle. Consistently, muscle-specific CD47-knockout mice show similar metabolic improvements, indicating a direct muscle-specific role of CD47 in regulating AMPK activation in vivo. Furthermore, the CD47-blocking antibody reduces the phosphorylation of heat shock protein 90α (HSP90α) to activate AMPK in skeletal muscle. In conclusion, CD47-blocking antibody confers metabolic benefits by activating the AMPK pathway in skeletal muscle.

Cell Reports MedicineVol. 6(5)
Tongji University (CN), Karolinska Institutet (SE), Nanjing University (CN)
Zero hunger
Openalex Percentile: Top 12%
Phagocytosis and Immune Regulation
2.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.